---
figid: PMC5488809__nihms869303f2
figlink: /pmc/articles/PMC5488809/figure/F2/
number: F2
caption: Genetic alterations of key components of the growth factor receptor-PI3K-Akt
  signaling pathway are frequently observed in primary (IDH wild-type) GBM, which
  eventually activate mTOR signaling. c-Myc, a master regulator of cancer metabolism
  is transcriptionally and functionally regulated by two distinct mTOR complexes,
  mTORC1 and mTORC2. This circuit of metabolic shifting causes GBM cell resistance
  to molecularly targeted therapies by maintaining elevated levels of c-Myc. Interestingly,
  RTK- and Myc-dependent metabolic reprogramming might be also involved in malignant
  progression of IDH-mutant gliomas.del, deletion; EGFRvIII, epidermal growth factor
  receptor variant III; mut, mutation; PI3K, phosphoinositide 3-kinase; PIK3CA, phosphatidylinositol
  (4,5)-bisphosphate 3-kinase catalytic subunit alpha; PIP2, phosphatidylinositol
  (4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PTEN, phosphatase
  and tensin homolog deleted on chromosome 10.
pmcid: PMC5488809
papertitle: Cancer metabolism as a central driving force of glioma pathogenesis.
reftext: Kenta Masui, et al. Brain Tumor Pathol. ;33(3):161-168.
pmc_ranked_result_index: '8830'
pathway_score: 0.9449013
filename: nihms869303f2.jpg
figtitle: Cancer metabolism as a central driving force of glioma pathogenesis
year: ''
organisms:
- Homo sapiens
ndex: 1a4c20db-def2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5488809__nihms869303f2.html
  '@type': Dataset
  description: Genetic alterations of key components of the growth factor receptor-PI3K-Akt
    signaling pathway are frequently observed in primary (IDH wild-type) GBM, which
    eventually activate mTOR signaling. c-Myc, a master regulator of cancer metabolism
    is transcriptionally and functionally regulated by two distinct mTOR complexes,
    mTORC1 and mTORC2. This circuit of metabolic shifting causes GBM cell resistance
    to molecularly targeted therapies by maintaining elevated levels of c-Myc. Interestingly,
    RTK- and Myc-dependent metabolic reprogramming might be also involved in malignant
    progression of IDH-mutant gliomas.del, deletion; EGFRvIII, epidermal growth factor
    receptor variant III; mut, mutation; PI3K, phosphoinositide 3-kinase; PIK3CA,
    phosphatidylinositol (4,5)-bisphosphate 3-kinase catalytic subunit alpha; PIP2,
    phosphatidylinositol (4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate;
    PTEN, phosphatase and tensin homolog deleted on chromosome 10.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TERT
  - MAPKAP1
  - RICTOR
  - MUT
  - MLST8
  - MTOR
  - PTEN
  - PIK3CD
  - PIK3R6
  - IDH2
  - ATRX
  - MYC
  - PIK3R5
  - PIK3R4
  - RPTOR
  - PIK3CA
  - IDH1
  - TP53
  - PIK3R3
  - PIK3CG
  - PIK3CB
genes:
- word: TERT
  symbol: TERT
  source: hgnc_symbol
  hgnc_symbol: TERT
  entrez: '7015'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: mut)
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IDH1/2
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ATRX
  symbol: ATRX
  source: hgnc_symbol
  hgnc_symbol: ATRX
  entrez: '546'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IDH1/2
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PIK3CA
  symbol: PIK3CA
  source: hgnc_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals: []
diseases: []
figid_alias: PMC5488809__F2
redirect_from: /figures/PMC5488809__F2
figtype: Figure
---
